A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

NCT00128830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus Type 1

Interventions

DRUG: Etravirine (ETR)
DRUG: Nucleotide reverse transcriptase inhibitors (NRTIs)
DRUG: Protease inhibitors (PIs)
DRUG: Enfuvirtide (ENF)

Sponsor

Tibotec Pharmaceuticals, Ireland